Skip to Content

Diazoxide Pregnancy and Breastfeeding Warnings

Diazoxide is also known as: Hyperstat, Hyperstat IV, Proglycem

Medically reviewed by Last updated on Dec 3, 2018.

Diazoxide Pregnancy Warnings

Diazoxide has been assigned to pregnancy category C by the FDA. It is not indicated for use during pregnancy. Animal studies have shown evidence of reduced fetal growth and fetal and/or pup survival in addition to prolonged parturition. There are no adequate or controlled data from human pregnancy studies. Diazoxide should only be used during pregnancy when need has been clearly established.

If given during labor, diazoxide may stop uterine contractions, requiring use of an oxytocic agent.

See references

Diazoxide Breastfeeding Warnings

There are no data on the excretion of diazoxide into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Hyperstat I.V. (diazoxide)." Schering Corp, Kenilworth, NJ.

References for breastfeeding information

  1. "Product Information. Hyperstat I.V. (diazoxide)." Schering Corp, Kenilworth, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.